# Neural Mechanisms and Efficacy of Dual Neurotechnology-aided Mirror Therapy in Chronic Stroke: Neural and Motor Plasticity, Movement Performance, Daily Function, and Quality of Life

Study · id `cardio:ct-nct04326205` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04326205](<https://clinicaltrials.gov/study/NCT04326205>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04326205

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 112 participants.

## Technical summary

Registry record NCT04326205. Randomized; single masking; primary purpose treatment. Start 2021-04-14 (actual); primary completion 2023-07-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 112 participants (planned count; ClinicalTrials.gov record NCT04326205, source copy `cardio:ctgov-nct04326205-2021-05-17`, retrieved 2026-10-26)
- Started: 2021-04-14 (actual) (ClinicalTrials.gov record NCT04326205, source copy `cardio:ctgov-nct04326205-2021-05-17`, retrieved 2026-10-26)
- Primary completion: 2023-07-31 (anticipated) (ClinicalTrials.gov record NCT04326205, source copy `cardio:ctgov-nct04326205-2021-05-17`, retrieved 2026-10-26)
- Completion: 2023-07-31 (anticipated) (ClinicalTrials.gov record NCT04326205, source copy `cardio:ctgov-nct04326205-2021-05-17`, retrieved 2026-10-26)
- Countries: Taiwan (ClinicalTrials.gov record NCT04326205, source copy `cardio:ctgov-nct04326205-2021-05-17`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04326205-2021-05-17`, retrieved 2026-10-26)

## The registry's words

- Brief title: Neural Mechanisms and Efficacy of Dual Neurotechnology-aided Mirror Therapy in Chronic Stroke: Neural and Motor Plasticity, Movement Performance, Daily Function, and Quality of Life
- Condition: Cerebrovascular Accident
- Intervention (Device): transcranial direct current stimulation, tDCS
- Intervention (Device): functional electrical stimulation, FES
- Intervention (Other): no stimulation
- Lead sponsor: Chang Gung Memorial Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Chang Gung Memorial Hospital (`cardio:org-chang-gung-memorial-hospital`)

## Provenance

Content hash: 402591538bcc81da7ed28798d0c02d170d7ed430f369f34343522bbd9a215d54
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
